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Abstract 
Substantial data demonstrate that the early life environment, including in utero, plays 
a key role in later life disease. In particular, maternal stress during pregnancy has 
been linked to adverse behavioural and emotional outcomes in children. Data from 
human cohort studies and experimental animal models suggest that modulation of 
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the developing epigenome in the fetus by maternal stress may contribute to the fetal 
programming of disease. Here, we summarise insights gained from recent studies 
that may advance our understanding of the role of the placenta in mediating the 
association between maternal mood disorders and offspring outcomes. Firstly, the 
placenta provides a record of exposures during pregnancy, which can be evidenced 
by changes in the placental trancriptome and epigenome. Secondly, prenatal 
maternal mood may alter placental function to adversely impact fetal and child 
development. Finally, we discuss the less well established but interesting possibility 
that altered placental function, more specifically changes in placental hormones, may 
adversely affect maternal mood and later maternal behaviour, which can also have 
consequence for offspring wellbeing.  
 
Introduction 
Pregnancy can be a challenging time in a woman’s life where she may experience 
many changes in her circumstances. Pregnancy can also be a time of vulnerability to 
perinatal mental illnesses including depression, stress and postnatal psychosis [1]. In 
the UK, it is estimated that maternal mood disorders, either prenatally or in the 
immediate period after birth, affect approximately 1 in 5 women, and is therefore one 
of the most common conditions of pregnancy. These disorders affect women of all 
ethnicities, nationalities and social strata [2]. In addition to the distress this causes 
women and their families, mental health disorders are one of the leading causes of 
death during pregnancy and the year after birth [1]. Of equal concern is an additional 
consequence for her child’s wellbeing, with an increased risk of adverse behavioural 
and metabolic outcomes following exposure to maternal prenatal stress [3]. Thus, a 
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greater understanding of both the causes and the consequences of prenatal 
maternal stress and mood disorders is imperative.  
 
Fetal programming by maternal stress 
Prenatal stress at its broadest level includes major life event stress, catastrophic 
disasters, chronic stress, daily hassles, perceived stress or pregnancy-specific 
anxiety along with related symptoms of depression or general anxiety during 
pregnancy [4]. Both animal and human studies indicate that maternal prenatal stress 
is associated with an increased risk of adverse emotional, behavioural and cognitive 
outcomes in the offspring, a subject that has been extensively reviewed (for example 
[5, 6]). Several studies, including the large Avon Longitudinal Study of Parents and 
Children (ALSPAC) cohort, allow for multiple confounders, including prenatal 
paternal and postnatal maternal mood. The findings from such studies indicate that 
the increased risk for adverse outcomes in the offspring are programmed in utero by 
the maternal emotional state, in least in part [7]. If the mother is in the top 15% of a 
normal population for prenatal symptoms of anxiety or depression, her child has 
double the risk of a probable mental disorder, raised from about 6% to 12% at the 
age of 13 years [7]. However, it is also clear that not all children are affected equally 
by exposure to maternal stress, and also the effects of prenatal stress on child 
development are inconsistent. Recent data suggests that this may be, in part, due to 
gene/environment interplay, including the interaction between prenatal maternal 
anxiety with the child brain-derived neurotrophic factor (BDNF) [8] and catechol-O-
methyltransferase (COMT) (O’Donnell et al., in preparation) genotypes, in the 
development of emotional and cognitive outcomes, respectively.  
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The role of the placenta in mediating fetal programming 
Placental function is important both for optimal fetal growth and maternal health [9]. 
The placenta is a transient organ of pregnancy that transports nutrients and oxygen 
to the growing fetus and removes waste products. Additionally, the placenta 
functions to mitigate the mother’s immune response to her semi-allogeneic fetus and 
manufactures large quantities of hormones that flood the maternal system to induce 
the adaptations required for a successful pregnancy [10]. An optimally functioning 
placenta can provide protection to the fetus against some forms of prenatal 
adversity. For example, the placental enzyme 11β-hydroxysteroid dehydrogenase 2 
(HSD11B2) regulates fetal exposure to maternal cortisol by converting it to inactive 
cortisone. Thus the placenta is able to partially protect the fetus against elevated 
maternal cortisol levels. However, there is evidence that placental function may be 
affected by prenatal stress [11-15]. Both endogenous and synthetic glucocorticoids 
have been shown to impact a variety of placental functions, including vascularisation, 
apoptosis and nutrient transport, in a range on animal models and human studies 
[16-20]. Moreover, there is evidence that other maternal factors, such as 
catecholamines [21], may transfer the effects of maternal stress to the fetus by 
altering placental function. Consequently, suboptimal placental function, induced by 
the maternal state may contribute to altered, and in our environment, poorer 
outcomes for children [22]. Prenatal anxiety is associated with both lower expression 
and activity of placental HSD11B2 [14], potentially mitigating the protective role this 
enzyme usually plays, and theoretically exposing the fetus to higher cortisol levels. 
Fetal glucocorticoid exposure is also regulated by the placental glucocorticoid (GR; 
NR3C1) and mineralocorticoid (MR; NR3C2) receptors. Placental NR3C1 and 
NR3C2 expression is higher among depressed compared to non-depressed new 
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mothers, providing another mechanism for programming of adverse offspring 
outcomes [15]. Alterations in the expression of placental cortiticotropin releasing 
hormone (pCRH; stimulates the production of cortisol via the HPA axis), monoamine 
oxidase A (MAOA; metabolises serotonin into 5-hydroxyindoleacetic acid) and 
placental serotonin transporter (SLC6A4; transports the neurotransmitter serotonin) 
and P-glycoprotein have also been linked to prenatal stress [11, 23-25]. Interestingly, 
very recent evidence suggests that the associations between prenatal maternal 
mood and placental gene expression may be different in Caucasian and non-
Caucasian populations (Capron et al., in preparation). Thus, alterations in the 
expression of a number of genes in the placenta may mediate aspects of fetal 
programming associated with prenatal stress (Figure 1), however these findings may 
have ethnic specificities.  
 
Maternal stress and epigenetic changes in the placenta 
Although it is clear that there are changes in the expression of genes in the placenta 
in relation to prenatal stress exposure, the mechanisms underpinning these changes 
are unclear. One possibility is epigenetic deregulation of gene expression. 
Epigenetics describes the marks or tags that are added or removed from DNA 
sequence and histones that regulate gene expression in a manner that is heritable 
through cell division. Such marks may be altered by exposure to stress during 
prenatal development, a period when the epigenome is rapidly changing [26]. Animal 
research demonstrates that maternal stress can induce epigenetic changes in the 
placenta; DNA methylation changes have been reported in the promoter region of 
Hsd11B2 [12] and altered chromatin methylation linked to O-linked-N-
acetylglucosamine transferase (Ogt) [27]. Such alterations may be mediated by sex-
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specific changes in the placental epigenetic machinery [28]. In humans, maternal 
anxiety has been linked to greater placental methylation of HSD11B2, while maternal 
depression (but not anxiety) has been associated with increased placental 
methylation of NR3C1 [29]. Recent research with mothers in a conflict-ridden region 
of the Democratic Republic of Congo has reported that higher levels of war trauma 
and chronic stress were associated with DNA methylation levels in multiple placental 
genes involved in HPA axis regulation, including: CRH, CRHBP, NR3C1, and FKBP5 
[30].  Stress-linked variation in DNA methylation was observed in placental tissue as 
well as maternal and umbilical cord blood. However, similar to Pena et al., (2012), 
the effects at individual CpG sites differed between tissues. The majority of CpG 
sites identified were situated in transcription factor binding regions, and several were 
associated with offspring birth weight [30]. Similar effects of maternal war trauma 
and chronic stress have been observed with placental BDNF methylation [31]. The 
observation that many affected CpG sites bind transcription factors, along with 
observed associations with mRNA levels or offspring birth weight suggests that 
stress-linked variation in placental methylation may have functional consequences 
for offspring outcomes. 
 
Maternal stress and epigenetic changes in offspring 
Experimental animal models have demonstrated that early life stress can leave a 
mark on the offspring epigenome, with alterations reported in offspring exposed to 
prenatal stress [28], maternal separation [32], and low levels of maternal postnatal 
care [33]. In humans, variation in CpG methylation in umbilical cord blood at NR3C1 
has been associated with prenatal maternal anxiety [34] and depressive symptoms 
[29, 35]. Also in cord blood, CpG methylation at both NR3C1 and CRH is associated 
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with maternal experiences of war trauma and chronic stress [30]. The NR3C1 and 
CRH CpG sites identified in these studies are the same as those linked with pre-
eclampsia in cord blood [36] or prenatal exposure to inter-partner violence in 
offspring venous blood [37]. In animal models, methylation at the NR3C1 sites 
affects NGFI-A binding [38]. These may be sites for which DNA methylation is 
particularly sensitive to several stress-linked phenotypes. Prenatal maternal chronic 
stress and war trauma is associated with BDNF methylation in cord blood at birth 
[31] and prenatal depression has been associated with DNA methylation at the 
BDNF promoter region in buccal cells at two months of age [39]. BDNF plays an 
essential role in brain development and has been linked to psychiatric risk [40], thus 
suggesting that BDNF DNA methylation may be an important target for future 
investigation. Maternal cortisol and self-reported depressive and anxiety symptoms 
has also been associated with altered DNA methylation of the imprinted genes IGF2 
and GNASXL [41]. However, it is important to note that across both rodent and 
human studies, there are tissue specific associations of prenatal stress and DNA 
methylation. These differences may reflect the different physiologic functions of each 
tissue or differences in the epigenetic status of certain tissues at the time of 
exposure. Nonetheless, it seems clear that the maternal stress can impact both the 
placental and the fetal epigenomes to alter gene expression.  
 
The programming of maternal mood by the placenta 
While considerable data from both animal models and human studies support 
changes in the placenta and fetus in response to maternal stress, which may then 
contribute to the programming of neurodevelopmental changes in offspring, few 
studies have explored a placental origin for maternal mood disorders. Pituitary 
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prolactin and the placental lactogens are a group of evolutionarily and functionally 
related hormones important in pregnancy. Human placental lactogen (hPL) is 
produced by the placental syncytiotrophoblast and secreted into the maternal 
circulation, replacing prolactin as the main lactogenic hormone during pregnancy 
[42]. Numerous studies highlight a functional role for these hormones and their 
shared receptor (prolactin receptor; PRLR) in the onset of maternal behaviours in 
rodents and, in the case of prolactin and PRLR, also maternal neurogenesis [43-53]. 
In humans, these hormones may contribute to suppression of anxiety related 
behaviours during pregnancy [54]. Decreased serum prolactin levels have been 
reported in human mothers with postnatal depression [55, 56] while increased levels 
of prolactin have been associated with low anxiety scores during pregnancy [57]. 
Impaired human placental lactogen (hPL) production has also been associated with 
adverse infant outcomes such as fetal growth restriction [58, 59]. Thus the altered 
placental expression of placental lactogen could contribute to both maternal mood 
disorders and adverse outcomes (Figure 1).  
 
Imprinted genes, fetal programming and maternal mood disorders. 
Imprinted genes are expressed from one parental allele through epigenetic marking 
in the germline [60]. Imprinted genes are known to regulate fetal growth, placental 
development, adult behaviour and metabolism [61]. These multifunctional roles and 
the flexibility of epigenetic marks has led to the suggestion that imprinted genes may 
contribute to the fetal programming of adverse outcomes [62]. Numerous studies 
have reported the aberrant expression of imprinted genes in the placenta in relation 
to fetal growth restriction and low birth weight [63]. Altered expression of imprinted 
genes in the placenta has also been linked to infant neurobehavioral developmental 
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outcomes [64, 65]. Recently, imprinted genes have been highlighted as key 
regulators of the endocrine lineages that express placental hormones in rodents [66]. 
This newly defined function suggests that the aberrant expression of imprinted genes 
in the placenta could contribute to the mispriming of maternal behaviour, at least in 
rodents, by modulating exposure of the maternal brain to key placental hormones 
such as the placental lactogens. If the function of imprinted genes in regulating the 
endocrine lineage of the human placenta was conserved across species, aberrant 
imprinting could help to explain the co-occurrence of low birth weight with prenatal 
mood disorders, which has been reported in a number of studies [67-73]. Epigenetic 
changes in cord blood DNA at imprinted loci have been associated with depressed 
maternal mood during pregnancy [74] and with maternal stress [41, 75]. One study 
reported changes in DNA methylation in both cord blood DNA and placental DNA at 
an imprinted locus [76]. While it is generally presumed that such changes occur in 
response to prenatal adversity with the focus primarily concerning offspring 
outcomes, it is possible that such changes contribute to altered maternal mood by 
changing the endocrine function of the placenta (Figure 1). Consistent with this 
hypothesis, recent data identifies a significant association between both symptoms 
of prenatal depression and clinically diagnosed depression with placental expression 
of both an imprinted gene and also placental lactogen, a hormone predicted to be 
regulated by this gene (Jannsen et al., under review). Determining cause and effect 
relationships in human studies of pregnancy is challenging. However, very recent 
work utilising a novel rodent model suggests that imprinted genes in the placenta 
can influence both the maternal neural transcriptome during pregnancy and maternal 
behaviour in the early postnatal period (Creeth et al, in prep), data that supports a 
causal relationship.  
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Summary and outlook 
In summary, the placenta plays a key role in supporting a successful healthy 
pregnancy. The placenta can provide a record of prenatal adversity, including 
maternal stress. Changes in placental function, potentially driven by epigenetic 
processes, may impact neurodevelopmental outcomes for children and both mental 
and metabolic health into adulthood. Importantly, placental dysfunction may also 
contribute to maternal mood disorders, either during pregnancy and/or in the 
immediate postnatal period, by exposing the mother to abnormal levels of placental 
hormones. At present most women experiencing heightened levels of prenatal 
depression, stress and anxiety are undetected and untreated. The potential clinical 
implications of maternal prenatal mood on fetal and child neurodevelopment are 
substantial. Better emotional care for all pregnant women and the enhanced 
identification and support for women at particularly high risk of maternal mood 
disorders will help not only them but also their children, and potentially subsequent 
generations.  
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Figure 1. The role of the placenta in prenatal stress 
Prenatal stress can influence the placental and fetal transcriptomes and 
epigenomes, which may contribute to adverse outcomes for children. Dysfunctional 
placental signaling may also influence maternal mood during pregnancy and 
maternal behaviour in the postnatal period further contributing to adverse outcomes. 
 
 
 
